Infection related hospitalizations after prostate biopsy in a statewide quality improvement collaborative

Journal of Urology

Volumn 191, Issue 6, 2014, Pages 1787-1792

  Womble, Paul R ^a   Dixon, Maxwell W ^a   Linsell, Susan M ^a   Ye, Zaojun ^a   Montie, James E ^a   Lane, Brian R ^b   Miller, David C ^a   Burks, Frank N ^c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b SPECTRUM HEALTH   (United States)

^c OAKLAND UNIVERSITY WILLIAM BEAUMONT SCHOOL OF MEDICINE   (United States)

Author keywords

anti bacterial agents; biopsy; complications; infection; prostate

Indexed keywords

AMOXICILLIN; AMPICILLIN; CEFUROXIME; COTRIMOXAZOLE; GENTAMICIN; PROSTATE SPECIFIC ANTIGEN; ANTIINFECTIVE AGENT; ANTIBIOTIC AGENT; CEFALEXIN; NITROFURANTOIN; PIPERACILLIN PLUS TAZOBACTAM; TMP SMX; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; DISEASE REGISTRY; FOLLOW UP; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; HUMAN TISSUE; INFECTION COMPLICATION; INFECTIOUS COMPLICATION; MAJOR CLINICAL STUDY; MALE; MICHIGAN UROLOGICAL SURGERY IMPROVEMENT COLLABORATIVE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PREVALENCE; PRIORITY JOURNAL; PROSTATE BIOPSY; PSEUDOMONAS AERUGINOSA; QUALITY CONTROL; TELEPHONE INTERVIEW; TOTAL QUALITY MANAGEMENT; ADVERSE EFFECTS; BACTERIAL INFECTIONS; BIOPSY; CLINICAL TRIAL; COMPARATIVE STUDY; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PROSTATE; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDY; STANDARDS; STATISTICS AND NUMERICAL DATA; VERY ELDERLY; BACTERIAL GROWTH; BACTERIAL INFECTION; CANCER REGISTRY; COST EFFECTIVENESS ANALYSIS; PROSTATE CANCER; PROSTATE SIZE; TELECONSULTATION;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; BACTERIAL INFECTIONS; BIOPSY; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PATIENT ADMISSION; PROSTATE; PROSTATIC NEOPLASMS; QUALITY IMPROVEMENT; RETROSPECTIVE STUDIES;

EID: 84900458621     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2013.12.026     Document Type: Article

References (14)

1. S. Loeb, H.B. Carter, and S.I. Berndt et al. Complications after prostate biopsy: data from SEER-Medicare J Urol 186 2011 1830
2. V.A. Moyer Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement Ann Intern Med 157 2012 120
3. A.A. Mosharafa, M.H. Torky, and W.M. El Said et al. Rising incidence of acute prostatitis following prostate biopsy: fluoroquinolone resistance and exposure is a significant risk factor Urology 78 2011 511
4. S. Minamida, T. Satoh, and K. Tabata et al. Prevalence of fluoroquinolone-resistant Escherichia coli before and incidence of acute bacterial prostatitis after prostate biopsy Urology 78 2011 1235
5. R.K. Nam, R. Saskin, and Y. Lee et al. Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy J Urol 189 suppl 2013 S12
6. A.K. Taylor, T.R. Zembower, and R.B. Nadler et al. Targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound guided prostate biopsy is associated with reduced incidence of postoperative infectious complications and cost of care J Urol 187 2012 1275
7. American Urological Association: Best Practice Policy Statement on Urologic Surgery Antimicrobial Prophylaxis (2008). Available at www.auanet.org/education/guidelines/antimicrobial-prophylaxis.cfm. Accessed October 2013.
8. D. Batura, and G.G. Rao The national burden of infections after prostate biopsy in England and Wales: a wake-up call for better prevention J Antimicrob Chemother 68 2013 247
9. F.M. Wagenlehner, E. van Oostrum, and P. Tenke et al. Infective complications after prostate biopsy: outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, a prospective multinational multicentre prostate biopsy study Eur Urol 63 2013 521
10. Wolf JS Jr, Chairman of AUA Best Practice Policy on Urologic Surgery Antimicrobial Prophylaxis: Personal communication, July 24, 2013.
11. M.A. Liss, K.K. Nakamura, and R. Meuleners et al. Screening rectal culture to identify fluoroquinolone-resistant organisms before transrectal prostate biopsy: do the culture results between office visit and biopsy correlate? Urology 82 2013 67
12. M. Adibi, B. Hornberger, and D. Bhat et al. Reduction in hospital admission rates due to post-prostate biopsy infections after augmenting standard antibiotic prophylaxis J Urol 189 2013 535
13. L.C. Remynse 3rd, P.J. Sweeney, and K.A. Brewton et al. Intravenous piperacillin/tazobactam plus fluoroquinolone prophylaxis prior to prostate ultrasound prostate biopsy reduces serious infectious complications and is cost effective Open Access J Urol 3 2011 139
14. E.O. Kehinde, M. Al-Maghrebi, and M. Sheikh et al. Combined ciprofloxacin and amikacin prophylaxis in the prevention of septicemia after transrectal ultrasound guided biopsy of the prostate J Urol 189 2013 911